EXAS+96.76%13.8%
NTRA+72.53%12.3%
GH+219.91%10.8%
NEO+96.66%9.1%
QGEN-13.51%7.7%
VACY—6.9%
CSTL+23.79%6.1%
GRAL+74.67%6.1%
LH+9.46%5.4%
ABT-28.35%4.7%
ILMN+93.66%4.6%
MYGN+10.91%4.6%
DGX+21.35%4.5%
PSNL+111.71%2.3%
BDX+9.28%1.0%
As of Jul 10, 2026, 7:14 AM ET
MedTech Long '26: Diagnostics & Early Detection Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Abbott LaboratoriesABT | 4.7% | 0.01% | -0.82% | 1.82% | 2.41% | -24.27% | -18.87% | -27.10% | -28.35% | $164.43B |
Becton, Dickinson and CompanyBDX | 100.0% | -1.76% | 0.19% | -2.80% | -1.34% | -1.13% | -14.52% | -13.81% | 9.28% | $54.65B |
Natera, Inc.NTRA | 12.3% | 0.59% | 2.72% | 3.50% | 2.02% | 23.03% | 35.48% | 96.82% | 72.53% | $40.37B |
Illumina, Inc.ILMN | 4.6% | 1.50% | 3.17% | 6.99% | 5.37% | 47.73% | 44.10% | 136.64% | 93.66% | $29.32B |
Quest Diagnostics IncorporatedDGX | 4.5% | 2.14% | -0.08% | -2.16% | -3.69% | 19.89% | -1.82% | 24.48% | 21.35% | $23.03B |
Labcorp Holdings Inc.LH | 5.4% | -0.23% | -0.04% | -0.70% | -2.20% | 10.66% | -3.97% | 17.46% | 9.46% | $22.77B |
Guardant Health, Inc.GH | 10.8% | 1.47% | 5.06% | 6.73% | -3.92% | 60.64% | 74.74% | 277.28% | 219.91% | $21.76B |
Exact Sciences CorporationEXAS | 13.8% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 96.76% | $20.03B |
Qiagen N.V.QGEN | 7.7% | -0.17% | 10.50% | 5.53% | 7.31% | -6.63% | -15.68% | 4.92% | -13.51% | $8.66B |
GRAIL, Inc.GRAL | 6.1% | -0.05% | 8.06% | 10.82% | 11.28% | -11.45% | 42.38% | 189.94% | 74.67% | $3.25B |
Personalis, Inc.PSNL | 2.3% | 0.07% | 3.83% | 6.55% | 6.24% | 84.05% | 61.70% | 311.52% | 111.71% | $1.30B |
Castle Biosciences, Inc.CSTL | 6.1% | -4.21% | 3.89% | 0.99% | -0.61% | -36.86% | -16.94% | 21.64% | 23.79% | $744.9M |
Myriad Genetics, Inc.MYGN | 4.6% | 0.82% | 3.92% | 4.27% | 1.67% | -0.81% | 32.32% | -30.68% | 10.91% | $576.1M |
NeoGenomics, Inc.NEO | 9.1% | 0.07% | 3.44% | 3.37% | -1.60% | 25.26% | 49.85% | 56.37% | 96.66% | $383.6M |
—VACY | 6.9% | — | — | — | — | — | — | — | — | — |
| Theme return | — | 0.15% | 3.34% | 3.44% | 1.49% | 16.76% | 22.22% | 103.20% | 78.18% | — |
| Average | 6.7% | 0.02% | 3.13% | 3.21% | 1.64% | 13.82% | 19.30% | 85.78% | 57.06% | $27.95B |
| Median | 6.1% | 0.04% | 3.31% | 3.44% | 0.84% | 6.98% | 16.90% | 40.42% | 48.16% | $20.89B |
| Std Dev | 3.4% | 1.49% | 3.15% | 3.78% | 4.33% | 31.80% | 31.43% | 106.84% | 63.18% | $41.05B |
| Min | 100.0% | -4.21% | -0.82% | -2.80% | -3.92% | -36.86% | -18.87% | -30.68% | -28.35% | $383.6M |
| Max | 13.8% | 2.14% | 10.50% | 10.82% | 11.28% | 84.05% | 74.74% | 311.52% | 219.91% | $164.43B |
| % Positive Tickers | 57.14% | 71.43% | 71.43% | 50.00% | 57.14% | 57.14% | 78.57% | 85.71% |
About this theme
MedTech Long '26: Diagnostics & Early Detection tracks 15 publicly listed stocks in this theme. Sample tickers: ABT, BDX, CSTL, DGX, EXAS, GH, GRAL, ILMN, LH, MYGN, NEO, NTRA, and 3 more. Use the table below for the full list.